StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3060% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Precision BioSciences operating margin

Operating margin is operating income as a percentage of revenue.

Precision BioSciences's operating margin for the twelve months ending Jun 30, 2026 was -80.8%. For fiscal 2025 it was -152.2%, against -38.1% the year before. The highest annual figure on record is -34.1% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-152.2%−114.1
FY2024Dec 31, 2024-38.1%+51.7
FY2023Dec 31, 2023-89.8%+158.5
FY2022Dec 31, 2022-248.3%−214.2
FY2021Dec 31, 2021-34.1%+418.2
FY2020Dec 31, 2020-452.2%−60.1
FY2019Dec 31, 2019-392.1%+48.1
FY2018Dec 31, 2018-440.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-83.7%+76164.5
Q4 FY2025Dec 31, 202536.6%+3930.9
Q3 FY2025Sep 30, 2025-158976.9%−155283.3
Q2 FY2025Jun 30, 2025-121538.9%−121587.3
Q1 FY2025Mar 31, 2025-76248.3%−76224.5
Q4 FY2024Dec 31, 2024-3894.4%−3682.8
Q3 FY2024Sep 30, 2024-3693.6%−3599.3
Q2 FY2024Jun 30, 202448.4%+64.2
Q1 FY2024Mar 31, 2024-23.8%+128.3
Q4 FY2023Dec 31, 2023-211.6%−97.3
Q3 FY2023Sep 30, 2023-94.2%+105.1
Q2 FY2023Jun 30, 2023-15.8%+757.9
Q1 FY2023Mar 31, 2023-152.1%+672.0
Q4 FY2022Dec 31, 2022-114.3%+370.4
Q3 FY2022Sep 30, 2022-199.3%−151.3
Q2 FY2022Jun 30, 2022-773.7%−805.1
Q1 FY2022Mar 31, 2022-824.1%−709.5
Q4 FY2021Dec 31, 2021-484.7%−219.3
Q3 FY2021Sep 30, 2021-48.0%+305.7
Q2 FY2021Jun 30, 202131.4%+3074.9
Q1 FY2021Mar 31, 2021-114.6%+278.3
Q4 FY2020Dec 31, 2020-265.4%+69.8
Q3 FY2020Sep 30, 2020-353.7%+98.0
Q2 FY2020Jun 30, 2020-3043.4%−2600.5
Q1 FY2020Mar 31, 2020-392.9%−36.0
Q4 FY2019Dec 31, 2019-335.2%−9.2
Q3 FY2019Sep 30, 2019-451.8%−40.6
Q2 FY2019Jun 30, 2019-443.0%+204.1
Q1 FY2019Mar 31, 2019-356.9%+247.5
Q4 FY2018Dec 31, 2018-326.0%–
Q3 FY2018Sep 30, 2018-411.1%–
Q2 FY2018Jun 30, 2018-647.0%–
Q1 FY2018Mar 31, 2018-604.4%–

More Precision BioSciences figures

See a number that looks wrong?